YILMAZ, Y. 2013. Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials. CURRENT DRUG TARGETS , vol.14, no.11 , 1357-1366.

YILMAZ, Y., (2013). Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials. CURRENT DRUG TARGETS , vol.14, no.11, 1357-1366.

YILMAZ, YUSUF. "Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials," CURRENT DRUG TARGETS , vol.14, no.11, 1357-1366, 2013

YILMAZ, YUSUF. "Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials." CURRENT DRUG TARGETS , vol.14, no.11, pp.1357-1366, 2013

YILMAZ, Y. (2013) . "Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials." CURRENT DRUG TARGETS , vol.14, no.11, pp.1357-1366.

@article{article, author={YUSUF YILMAZ}, title={Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials}, journal={CURRENT DRUG TARGETS}, year=2013, pages={1357-1366} }